Gene · 54880
Papers3,332
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 3,332
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association between human leukocyte antigen and immunosuppressive treatment outcomes in Chinese patients with aplastic anemia. | Front Immunol | 2023 | 36793734 | PubTator, text mining | PubMed |
| A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl). | Eur J Cancer | 2023 | 36791667 | PubTator, text mining | PubMed |
| Impact of gene alterations on clinical outcome in young adults with myelodysplastic syndromes. | Sci Rep | 2023 | 36788335 | PubTator, text mining | PubMed |
| Expanding the Molecular Diversity of CIC-Rearranged Sarcomas With Novel and Very Rare Partners. | Mod Pathol | 2023 | 36788092 | PubTator, text mining | PubMed |
| Molecular-Based Immunohistochemical Algorithm for Uterine Leiomyosarcoma Diagnosis. | Mod Pathol | 2023 | 36788080 | PubTator, text mining | PubMed |
| CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult population. | Acta Neuropathol Commun | 2023 | 36782314 | PubTator, text mining | PubMed |
| A case report and literature review on nephrogenic alveolar soft part sarcoma: clinicopathological manifestations and genetic features. | BMC Urol | 2023 | 36782230 | PubTator, text mining | PubMed |
| Comparison of the mutation patterns between tumor tissue and cell-free DNA in stage IV gastric cancer. | Aging (Albany NY) | 2023 | 36779847 | PubTator, text mining | PubMed |
| Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma. | EMBO Mol Med | 2023 | 36779660 | PubTator, text mining | PubMed |
| Embryonal rhabdomyosarcoma of the uterine cervix in an adult female. | Autops Case Rep | 2023 | 36777814 | PubTator, text mining | PubMed |
| Emerging predictive biomarkers for novel therapeutics in peripheral T-cell and natural killer/T-cell lymphoma. | Front Immunol | 2023 | 36776886 | PubTator, text mining | PubMed |
| Current state of pediatric neuro-oncology imaging, challenges and future directions. | Neoplasia | 2023 | 36774835 | PubTator, text mining | PubMed |
| CD123 a Therapeutic Target for Acute Myeloid Leukemia and Blastic Plasmocytoid Dendritic Neoplasm. | Int J Mol Sci | 2023 | 36769040 | PubTator, text mining | PubMed |
| Molecular Identification and In Silico Protein Analysis of a Novel BCOR-CLGN Gene Fusion in Intrathoracic BCOR-Rearranged Sarcoma. | Cancers (Basel) | 2023 | 36765856 | PubTator, text mining | PubMed |
| Blastoid B-Cell Neoplasms: Diagnostic Challenges and Solutions. | Cancers (Basel) | 2023 | 36765805 | PubTator, text mining | PubMed |
| A systematic comparison of pan-Trk immunohistochemistry assays among multiple cancer types. | Histopathology | 2023 | 36759438 | PubTator, text mining | PubMed |
| Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamide. | Clin Epigenetics | 2023 | 36740715 | PubTator, text mining | PubMed |
| Genomic and Transcriptomic Characterization Revealed the High Sensitivity of Targeted Therapy and Immunotherapy in a Subset of Endometrial Stromal Sarcoma. | Cancer Res Treat | 2023 | 36731460 | PubTator, text mining | PubMed |
| Evaluation of Lineage/Site-specific Nuclear Immunohistochemical Markers SATB2, Cyclin D1, SALL4, and BCOR in High-grade Endometrial Carcinomas. | Int J Gynecol Pathol | 2023 | 36731037 | PubTator, text mining | PubMed |
| The clinical impact of the molecular landscape of acute myeloid leukemia. | Haematologica | 2023 | 36722402 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54880/papers?page=35